- Home
- HURN vs PTGX Comparison
HURN vs PTGX Comparison
Compare HURN & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURN
- PTGX
- Stock Information
- Founded
- HURN 2002
- PTGX 2006
- Country
- HURN United States
- PTGX United States
- Employees
- HURN N/A
- PTGX N/A
- Industry
- HURN Professional Services
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- HURN Consumer Discretionary
- PTGX Health Care
- Exchange
- HURN Nasdaq
- PTGX Nasdaq
- Market Cap
- HURN N/A
- PTGX 2.8B
- IPO Year
- HURN 2004
- PTGX 2016
- Fundamental
- Price
- HURN $115.91
- PTGX $47.91
- Analyst Decision
- HURN Strong Buy
- PTGX Strong Buy
- Analyst Count
- HURN 4
- PTGX 7
- Target Price
- HURN $131.75
- PTGX $52.83
- AVG Volume (30 Days)
- HURN 66.1K
- PTGX 450.1K
- Earning Date
- HURN 10-29-2024
- PTGX 11-08-2024
- Dividend Yield
- HURN N/A
- PTGX N/A
- EPS Growth
- HURN 14.29
- PTGX N/A
- EPS
- HURN 4.16
- PTGX 2.75
- Revenue
- HURN $1,425,021,000.00
- PTGX $319,120,000.00
- Revenue This Year
- HURN $11.16
- PTGX $400.33
- Revenue Next Year
- HURN $8.65
- PTGX N/A
- P/E Ratio
- HURN $25.27
- PTGX $17.54
- Revenue Growth
- HURN 12.76
- PTGX 125.73
- 52 Week Low
- HURN $84.26
- PTGX $13.76
- 52 Week High
- HURN $115.65
- PTGX $48.89
- Technical
- Relative Strength Index (RSI)
- HURN 66.87
- PTGX 60.40
- Support Level
- HURN $103.24
- PTGX $45.33
- Resistance Level
- HURN $108.75
- PTGX $48.89
- Average True Range (ATR)
- HURN 2.06
- PTGX 1.28
- MACD
- HURN 0.22
- PTGX 0.11
- Stochastic Oscillator
- HURN 100.00
- PTGX 77.11
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.